Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The clinical syndrome of generalized, compensated glucocorticoid resistance is characterized by increased cortisol secretion without clinical evidence of hyper- or hypocortisolism, and manifestations of androgen and/or mineralocorticoid excess. This condition results from partial failure of the glucocorticoid receptor (GR) to modulate transcription of its target genes. We studied the molecular mechanisms of this syndrome in a Dutch kindred, whose affected members had hypercortisolism and approximately half of normal GRs, and whose proband was a young woman with manifestations of hyperandrogenism. Using the polymerase chain reaction to amplify and sequence each of the nine exons of the GR gene alpha, along with their 5'- and 3'-flanking regions, we identified a 4-base deletion at the 3'-boundary of exon 6 in one GR allele (delta 4), which removed a donor splice site in all three affected members studied. In contrast, the sequence of exon 6 in the two unaffected siblings was normal. A single nucleotide substitution causing an amino acid substitution in the amino terminal domain of the GR (asparagine to serine, codon 363) was also discovered in exon 2 of the other allele (G1220) in the proband, in one of her affected brothers and in her unaffected sister. The functional importance of this mutation was tested in a cotransfection study using the recombinant expression vector pRShGR-Ser363 and the glucocorticoid responsive vector mouse mammary tumor virus-chloramphenicol transferas…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients may be homozygous for missense mutations (635) or heterozygous for a gene deletion (636), so that in each case some GR activity remains.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [636]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.
Picard, D., & Yamamoto, K. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02654.x · Cited by 970
Functional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918
Multiple and cooperative trans-activation domains of the human glucocorticoid receptor
Hollenberg, S. M., & Evans, R. M. (1988) · Cell · doi:10.1016/0092-8674(88)90145-6 · Cited by 684
Hollenberg, S. M., Giguere, V., Segui, P., & Evans, R. M. (1987) · Cell · doi:10.1016/0092-8674(87)90753-7 · Cited by 497
The genomic structure of the human glucocorticoid receptor.
Encío, I. J., & Detera-Wadleigh, S. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89627-6 · Cited by 392
Self-citationHurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370
Self-citationIntracellular Receptor Concentration Limits Glucocorticoid-Dependent Enhancer Activity*
Vanderbilt, J. N., Miesfeld, R., Maler, B. A., & Yamamoto, K. R. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-1-68 · Cited by 349
Mechanisms of Action of Steroid Hormones
O'Malley, B. W. (1971) · New England Journal of Medicine · doi:10.1056/nejm197102182840710 · Cited by 291
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Self-citationGlucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundSelf-citationMolecular Genetics of Human Blood Pressure Variation
Lifton, R. P. (1996) · Science · doi:10.1126/science.272.5262.676 · Cited by 629
HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium Disease
Richeldi, L., Sorrentino, R., & Saltini, C. (1993) · Science · doi:10.1126/science.8105536 · Cited by 446
The human glucocorticoid receptor: molecular basis of biologic function
Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P., & Charmandari, E. (2010) · Steroids · doi:10.1016/j.steroids.2009.09.002 · Cited by 436
Self-citationvan Rossum, E. F. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.333 · Cited by 381
“The number of patients diagnosed with cortisol resistance syndrome is low (i.e., Ϸ nine) (Brufsky et al., 1990; Hurley et al., 1991; Karl et al., 1993,1996a; Malchoff et al., 1993; Ruiz et al., 2001; Mendonca et al., 2002; Vottero et al., 2002).”
Backgroundvan Rossum, E. F. C., Koper, J. W., Huizenga, N. A. T. M., Uitterlinden, A. G., Janssen, J. A. M. J. L., Brinkmann, A. O., Grobbee, D. E., de Jong, F. H., van Duyn, C. M., Pols, H. A. P., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3128 · Cited by 329
“In the symptomatic patients with familial forms of GC resistance, missense mutations in the ligand binding domain of the GR gene, causing decreased ligand binding affinity, have been described (6,7), as well as a deletion of four base pairs at the boundary of exon 6 and intron 6, causing loss of a splice site and a 50…”
BackgroundSelf-citationA Healthy Body in a Healthy Mind--and Vice Versa--The Damaging Power of "Uncontrollable" Stress
Chrousos, G. P. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1842 · Cited by 297
Self-citationThe Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Yudt, M. R., & Cidlowski, J. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0106 · Cited by 275
THE NUCLEAR HORMONE RECEPTOR GENE SUPERFAMILY
Ribeiro, M. D., Kushner, P. D., & Baxter, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.443 · Cited by 260
Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
Glucocorticoid receptor variants: clinical implications
DeRijk, R. H., Schaaf, M., & de Kloet, E. R. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00062-6 · Cited by 251
Syndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235
Self-citationKoper, J. W., Stolk, R. P., de Lange, P., Huizenga, N. A. T. M., Molijn, G.-J., Pols, H. A. P., Grobbee, D. E., Karl, M., de Jong, F. H., Brinkmann, A. O., et al. (1997) · Human Genetics · doi:10.1007/s004390050425 · Cited by 235
Self-citationTsigos, C., & Chrousos, G. P. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30078-1 · Cited by 201
Self-citationCharmandari, E., Kino, T., Ichijo, T., & Chrousos, G. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0040 · Cited by 201
“(33) 4-bp deletion in exon-intron 6 hGR number: 50% of Heterozygous Hirsutism control Male-pattern hair loss Inactivation of the affected allele Menstrual irregularities”
BackgroundSelf-citationde Castro, M., Elliot, S. J., Kino, T., Bamberger, C. M., Karl, M., Webster, E., & Chrousos, G. P. (1996) · Molecular Medicine · doi:10.1007/bf03401643 · Cited by 195
Self-citationCorticosteroid receptor polymorphisms: Determinants of vulnerability and resilience
DeRijk, R. H., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.072 · Cited by 184
Bray, P. J., & Cotton, R. G. H. (2003) · Human Mutation · doi:10.1002/humu.10213 · Cited by 168
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
Tissing, W. J. E., Meijerink, J. P. P., den Boer, M. L., & Pieters, R. (2003) · Leukemia · doi:10.1038/sj.leu.2402733 · Cited by 167
Ruiz, M., Lind, U., Gåfvels, M., Eggertsen, G., Carlstedt‐Duke, J., Nilsson, L., Holtmann, M., Stierna, P., Wikström, A., & Werner, S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01323.x · Cited by 164
Paugh, S. W., Bonten, E. J., Savic, D., Ramsey, L. B., Thierfelder, W. E., Gurung, P., Malireddi, R. K. S., Actis, M., Mayasundari, A., Min, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3283 · Cited by 164
Tissue glucocorticoid resistance/hypersensitivity syndromes
Kino, T., Martino, M. U. D., Charmandari, E., Mirani, M., & Chrousos, G. P. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00218-8 · Cited by 165
Self-citationDeregulation of EIF4E: a novel mechanism for autism
Neves-Pereira, M., Müller, B., Massie, D., Williams, J. H. G., O’Brien, P. C. M., Hughes, A., Shen, S.-B., Clair, D. S., & Miedzybrodzka, Z. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066852 · Cited by 142
“are reported with hypertension, hypokalaemia and female masculinisation, but not autistic features.”
BackgroundGeller, D. S., Zhang, J., Zennaro, M.-C., Vallo-Boado, A., Rodriguez-Soriano, J., Furu, L., Haws, R., Metzger, D., Botelho, B., Karaviti, L., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111188 · Cited by 131
Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
Mendonca, B. B. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1805 · Cited by 135
Self-citationVottero, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2658 · Cited by 126
Self-citationNelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene
Karl, M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.124 · Cited by 129
Self-citationde Lange, P., Segeren, C. M., Koper, J. W., Wiemer, E., Sonneveld, P., Brinkmann, A. O., White, A., Brogan, I. J., de Jong, F. H., & Lamberts, S. W. J. (2010) · Cancer Research · doi:10.1158/0008-5472.3937.61.10 · Cited by 121
Self-citationShahidi, H., Vottero, A., Stratakis, C. A., Taymans, S. E., Karl, M., Longui, C. A., Chrousos, G. P., Daughaday, W. H., Gregory, S. A., & PLATE, J. M. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9980 · Cited by 126
Self-citationGlucocorticosteroid Therapy in Childhood Acute Lymphoblastic Leukemia
Gaynon, P. S., & Carrel, A. L. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_66 · Cited by 133
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
Hawkins, G. A., Lazarus, R., Smith, R. S., Tantisira, K. G., Meyers, D. A., Peters, S. P., Weiss, S. T., & Bleecker, E. R. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.049 · Cited by 114
de KLOET, E. R., & DERIJK, R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.003 · Cited by 109
de Lange, P. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1156 · Cited by 117
Self-citationTaymans, S. E., DeVries, A. C., DeVries, M. B., Nelson, R. J., Friedman, T. C., Castro, M., Detera-Wadleigh, S., Carter, C. S., & Chrousos, G. P. (1997) · General and Comparative Endocrinology · doi:10.1006/gcen.1996.6849 · Cited by 112
Self-citationGlucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
Kino, T., & Chrousos, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690437 · Cited by 109
Self-citationAssociation of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant
Lin, R. C. Y., Wang, X. L., & Morris, B. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000055342.40301.dc · Cited by 106
Kino, T., Stauber, R. H., Resau, J. H., Pavlakis, G. N., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8017 · Cited by 105
Self-citationCharmandari, E., Raji, A., Kino, T., Ichijo, T., Tiulpakov, A., Zachman, K., & Chrousos, G. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1920 · Cited by 103
Self-citationClinical aspects of glucocorticoid sensitivity
Lamberts, S. W. J., Huizenga, A. T. M., de Lange, P., de Jong, F. H., & Koper, J. W. (1996) · Steroids · doi:10.1016/0039-128x(96)00005-0 · Cited by 99
Self-citationDiagnosis and treatment of low‐renin hypertension
Mulatero, P., Verhovez, A., Morello, F., & Veglio, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02898.x · Cited by 111
Charmandari, E., Kino, T., Souvatzoglou, E., Vottero, A., Bhattacharyya, N., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030450 · Cited by 99
Self-citationCurrent concepts in glucocorticoid resistance
Yang, N., Ray, D. W., & Matthews, L. C. (2012) · Steroids · doi:10.1016/j.steroids.2012.05.007 · Cited by 105
The Glucocorticoid Receptor Gene and Its Association to Metabolic Syndrome
Rosmond, R. (2002) · Obesity Research · doi:10.1038/oby.2002.146 · Cited by 89
McMahon, S. K., Pretorius, C. J., Ungerer, J. P. J., Salmon, N. J., Conwell, L. S., Pearen, M. A., & Batch, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1003 · Cited by 88
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-71 · Cited by 83
“[33] 4 bp deletion in hGRα number: 50% of control Heterozygous Hirsutism”
BackgroundSelf-citationCharmandari, E., Kino, T., Ichijo, T., Jubiz, W., Mejia, L., Zachman, K., & Chrousos, G. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2830 · Cited by 80
Self-citationAssociation of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant
Lin, R. C. Y., Wang, X. L., Dalziel, B., Caterson, I. D., & Morris, B. J. (2003) · Obesity Research · doi:10.1038/oby.2003.111 · Cited by 83
Charmandari, E., Kino, T., & Chrousos, G. P. (2013) · Endocrine Development · doi:10.1159/000342505 · Cited by 81
Self-citationTissing, W. J. E., Meijerink, J. P. P., den Boer, M. L., Brinkhof, B., van Rossum, E. F. C., van Wering, E. R., Koper, J. W., Sonneveld, P., & Pieters, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2097 · Cited by 82
Karanth, S. (1997) · Endocrinology · doi:10.1210/en.138.8.3476 · Cited by 79
Huizenga, N. A. T. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2076 · Cited by 75
Self-citationFamilial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms
CHARMANDARI, E., KINO, T., & CHROUSOS, G. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.014 · Cited by 76
Self-citationGross, C., Musiol, I. M., Eccleshall, T. R., Malloy, P. J., & Feldman, D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7986 · Cited by 75
Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo.
Hillmann, A. G., Ramdas, J., Multanen, K., Norman, M. R., & Harmon, J. M. (2000) · PubMed · Cited by 84
Irving, J. A. E., Minto, L., Bailey, S., & Hall, A. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1227 · Cited by 80
Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach
van Rossum, E. F. C., & Lamberts, S. W. J. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.005 · Cited by 77
Self-citationGlucocorticoid and mineralocorticoid receptors and associated diseases
Kino, T., & Chrousos, G. P. (2004) · Essays in Biochemistry · doi:10.1042/bse0400137 · Cited by 67
Self-citationGlucocorticoid Sensitivity in Young Healthy Individuals:in Vitro and in Vivo Studies
Chriguer, R. S., Elias, L. L. K., da Silva, I. M., Vieira, J. G. H., Moreira, A. C., & de Castro, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0067 · Cited by 68
Glucocorticoid Receptor β: View I
Vottero, A., & Chrousos, G. P. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00179-4 · Cited by 76
Self-citationCreed, T., & Probert, C. S. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03156.x · Cited by 73
Charmandari, E., Kino, T., Ichijo, T., Zachman, K., Alatsatianos, A., & Chrousos, G. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1893 · Cited by 63
Self-citationThe Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
Baudrand, R., & Vaidya, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020546 · Cited by 68
Huizenga, N. A. T. M., de Lange, P., Koper, J. W., Clayton, R. N., Farrell, W. E., van der Lely, A. J., Brinkmann, A. O., de Jong, F. H., & Lamberts, S. W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4648 · Cited by 64
Self-citationChrousos syndrome: from molecular pathogenesis to therapeutic management
Nicolaides, N. C., & Charmandari, E. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12426 · Cited by 67
Ray, D. W., Littlewood, A. C., Clark, A. J., Davis, J. R., & White, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117143 · Cited by 67
Laudet, V., & Gronemeyer, H. (2002) · Elsevier eBooks · doi:10.1016/b978-012437735-6/50032-1 · Cited by 63
Vannucchi, G. M., Covelli, D., Campi, I., Origo, D., Currò, N., Cirello, V., Dazzi, D., Beck‐Peccoz, P., & Salvi, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0611 · Cited by 63
Van Rossum, E. F. C., Roks, P. H. M., De Jong, F. H., Brinkmann, A. O., Pols, H. A. P., Koper, J. W., & Lamberts, S. W. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02132.x · Cited by 59
Self-citationJewell, C. M., & Cidlowski, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0642 · Cited by 60
“These results support most of the previous reports (5,6,20,21), although recently Russcher et al.”
BackgroundResultInfluentialCharmandari, E., & Kino, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02336.x · Cited by 61
Pharmacogenetics Influence Treatment Efficacy in Childhood Acute Lymphoblastic Leukemia
Davidsen, M. L., Dalhoff, K., & Schmiegelow, K. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181868570 · Cited by 60
de Lange, P., Koper, J. W., Brinkmann, A. O., Jong, F. H. D., & Lamberts, S. W. J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00072-6 · Cited by 71
Self-citationPrimary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update
Nicolaides, N. C., & Charmandari, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910839 · Cited by 58
Syndromes of glucocorticoid and mineralocorticoid resistance
Arai, K., & Chrousos, G. P. (1995) · Steroids · doi:10.1016/0039-128x(94)00007-y · Cited by 56
Self-citationPseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor
Komesaroff, P. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.27 · Cited by 55
Arai, K., Tsigos, C., Suzuki, Y., Irony, I., Karl, M., LISTWAK, S. J., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962269 · Cited by 58
Self-citationStructural Determinants of Cortisol Resistance in the Guinea Pig Glucocorticoid Receptor1
Keightley, M.-C., Curtis, A. J., Chu, S., & Fuller, P. J. (1998) · Endocrinology · doi:10.1210/endo.139.5.5982 · Cited by 53
Nuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
“For example, a single amino acid substitution in the GR LBD resulted in reduced binding affinity for glucocorticoids [278], while altered splicing of exon 6 led to FGR in a female patient presenting with hirsutism, menstrual abnormalities, and acne due to ACTH-induced hyper-secretion of androgens [279].”
BackgroundFeng, J., Zheng, J., Bennett, W. P., Heston, L. L., Jones, I. R., Craddock, N., & Sommer, S. S. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000612)96:3<412::aid-ajmg33>3.0.co;2-c · Cited by 53
Nicolaides, N. C., & Charmandari, E. (2017) · Hormones · doi:10.14310/horm.2002.1728 · Cited by 52
Primary Generalized Glucocorticoid Resistance and Hypersensitivity
Charmandari, E. (2011) · Hormone Research in Paediatrics · doi:10.1159/000330759 · Cited by 52
Familial/Sporadic Glucocorticoid Resistance Syndrome and Hypertension
KINO, T., VOTTERO, A., CHARMANDARI, E., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04416.x · Cited by 51
Self-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome
Vitellius, G., & Lombès, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0811 · Cited by 54
Anomalies in the Endocrine Axes of the Guinea Pig: Relevance to Human Physiology and Disease*
Keightley, M.-C., & Fuller, P. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-30 · Cited by 59
Vitellius, G., Trabado, S., Hoeffel, C., Bouligand, J., Bennet, A., Castinetti, F., Decoudier, B., Guiochon-Mantel, A., Lombes, M., Delemer, B., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1071 · Cited by 50
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Lin, R. C. Y., Wang, W. Y. S., & Morris, B. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1186 · Cited by 52
Glucocorticoid receptors and Cushing's disease
Lamberts, S. W. J. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00280-0 · Cited by 54
Self-citationFunction/Activity of Specific Amino Acids in Glucocorticoid Receptors
Simons, S. S. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61146-2 · Cited by 49
The Glucocorticoid Receptor and RU 486 in Man
BAMBERGER, C. M., & CHROUSOS, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31385.x · Cited by 49
Self-citationBriassoulis, G., Damjanovic, S., Xekouki, P., Lefebvre, H., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep11061.ra · Cited by 48
Self-citationGlucocorticoid Feedback Resistance
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00205-6 · Cited by 55
Cortisol resistance and the guinea pig glucocorticoid receptor
Keightley, M.-C., & Fuller, P. J. (1995) · Steroids · doi:10.1016/0039-128x(94)00014-4 · Cited by 46
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Strategies for the Characterization of Disorders in Cortisol Sensitivity
Russcher, H., Smit, P., van Rossum, E. F. C., van den Akker, E. L. T., Brinkmann, A. O., de Heide, L. J. M., de Jong, F. H., Koper, J. W., & Lamberts, S. W. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2212 · Cited by 43
Self-citationArai, K., Tsigos, C., Suzuki, Y., LISTWAK, S. J., Zachman, K., Zangeneh, F., Rapaport, R., Chanoine, J., & Chrousos, G. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883835 · Cited by 43
Self-citationA novel mutation of the hGR gene causing Chrousos syndrome
Nicolaides, N. C., Geer, E. B., Vlachakis, D. P., Roberts, M. L., Psarra, A. G., Moutsatsou, P., Sertedaki, A., Κοσσίδα, Σ., & Charmandari, E. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12470 · Cited by 42
Metadata
- Authors
- Karl, M., Lamberts, S. W., Detera-Wadleigh, S. D., Encio, I. J., Stratakis, C. A., Hurley, D. M., Accili, D., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1993-03
- Volume
- 76
- Issue
- 3
- Pages
- 683-689
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1968680063
- Cited by
- 241
- References
- 29
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 2 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- glucocorticoid receptor gene, exon 6 deletion, hypercortisolism, hyperandrogenism, null alleles, amino acid substitutions, N-terminal domain
- MeSH terms
- Adult, Amino Acid Sequence, DNA, Recombinant, Drug Resistance, Female, Glucocorticoids, Humans, Male, Molecular Sequence Data, Mutation, Nucleic Acid Hybridization, Pedigree, Receptors, Glucocorticoid, Polymerase Chain Reaction, Gene Deletion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.